Ethambutol/isoniazid/rifampicin

Last updated
Ethambutol/isoniazid/rifampicin
Combination of
ethambutol anti-tuberculosis medication
isoniazid anti-tuberculosis medication
rifampicin anti-tuberculosis medication
Clinical data
ATC code
Identifiers
CAS Number
ChemSpider
  • none

Ethambutol/isoniazid/rifampicin, also known as ethambutol/isoniazid/rifampin, is a fixed-dose combination medication used to treat tuberculosis. [1] It contains ethambutol, isoniazid, and rifampicin. [1] It is used either alone or with other anti-tuberculosis medication. [1] It is taken by mouth. [1] Side effects are those of the underlying medications. [1] Use may not be suitable in children. [1]

Contents

It is on the World Health Organization's List of Essential Medicines. [2]

See also

References

  1. 1 2 3 4 5 6 World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 142. hdl:10665/44053. ISBN   9789241547659.
  2. ↑ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl: 10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.